CD8A and neoplasm: For instance, Norian et al. found that MHC-II+CD11b+CD11chigh DCs infiltrating established mammary carcinomas could also act as regulatory players by inhibiting CD8 T cell function through l-Arginase production, thus dampening T cell-mediated anti-tumor immune protection (29).